TABLE 1.
Baseline characteristics of patients at the time of ablation
| Row labels | All patients | PAF | PsAF |
PAF vs PsAF P value |
|---|---|---|---|---|
| (n = 70) | (n = 40) | (n = 30) | ||
| Age (SD) | 64.5 ± 8.9 | 64,5 ± 9 | 64 ± 9 | P =.20 |
| Male | 47 (67.1%) | 25 (62.5%) | 22 (73.3%) | |
| Hypertension | 58 (82.8%) | 30 (75%) | 28 (93.3%) | P =.04 |
| Diabetes | 14 (20%) | 5 (12.5%) | 9 (30%) | P =.07 |
| Obese (BMI ≥ 30) | 18 (25.7%) | 7 (17.5%) | 11(36.7%) | P =.47 |
| Overweight (BMI ≥ 25) | 45 (64.3%) | 28 (70%) | 17 (56.7%) | P =.19 |
| CAD | 10 (14.3%) | 6 (60%) | 4 (40%) | P >.5 |
| Type of AF | 40 (57.2%) | 30 (42.8%) | ||
| AF duration | ||||
| ≥48 m | 27 (38.6%) | 14 (35%) | 13 (43.3%) | P =.07 |
| ≤36 m | 40 (57.1%) | 23 (57.5%) | 17 (43.5%) | P =.72 |
| LVEF ≥ 30% | 8 (11.43%) | 4 (50%) | 4 (50%) | P =.07 |
| LVEF ≥ 50% | 62 (88.57%) | 36 (58%) | 26 (42%) | P =.01 |
| LA volume (ml/m2) | ||||
| ≥28 | 37 (53%) | 13 (35%) | 24 (65%) | P <.0001 |
| <28 | 33 (47%) | 27 (82%) | 6 (18%) | P <.0001 |
Values are expressed as numbers and percentages.
Abbreviationss: AF, Atrial Fibrillation; BMI, body mass index; BSA, body surface area; CAD, coronary artery disease; LA, Left Atrium, LVEF, Left Ventricular Ejection Fraction; m, months; ml/my, milliliters per square meter; PAF, paroxysmal AF; PsAF, persistent AF; SD, standard deviation.